• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酰转肽酶与血小板比值及甘油三酯测定在非酒精性脂肪性肝病诊断中的临床价值:一项横断面研究

Clinical value of -glutamyl transpeptidase to platelet ratio and triglyceride measurement in the diagnosis of nonalcoholic fatty liver disease: A cross-sectional study.

作者信息

Zhan Haohong, Nong Xiaoli, Zhu Senzhi, Luo Ting, Li Tian, Cao Mingjing, Li Qi, He Zhuosen, Hu Junyan, Liu Xi

机构信息

Department of Emergency Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Department of Ultrasound, The Second Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

Heliyon. 2024 Aug 13;10(16):e36193. doi: 10.1016/j.heliyon.2024.e36193. eCollection 2024 Aug 30.

DOI:10.1016/j.heliyon.2024.e36193
PMID:39224338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11367536/
Abstract

OBJECTIVE

In clinical practice, there are few effective biomarkers for identifying non-alcoholic fatty liver disease (NAFLD). The aim of this study is to investigate the diagnostic value of γ-glutamyl transpeptidase to platelet ratio (GPR) combined with triglyceride (TG) in NAFLD.

METHODS

A total of 14,415 individuals participated in the annual physical examination. Multivariate logistic regression analysis was conducted to investigate the exposure factors associated with NAFLD. Spearman's analysis was performed to assess the correlation among the exposure factors of NAFLD. Furthermore, the diagnostic efficacy of the combination of GPR and TG in NAFLD was analyzed using the receiver operating characteristic curve (ROC).

RESULTS

The results of the multivariate logistic regression analysis showed that BMI (OR = 1.619), Systolic Blood Pressure (SBP) (OR = 1.014), Diastolic Blood Pressure (DBP) (OR = 1.028), GPR (OR = 12.809), and TG (OR = 2.936) were all risk factors for NAFLD, while HDL-C (OR = 0.215) was a protective factor. Spearman correlation analysis revealed significant positive correlations between GPR and SBP, DBP, BMI, TG (p < 0.01), but a negative correlation between GPR and HDL-C (p < 0.01). TG was only positively correlated with GPR (p < 0.001). ROC curve analysis demonstrated that the area under the curve (AUC) of GPR combined with TG for diagnosis of NAFLD was 0.855 (95 % CI: 0.819-0.891), sensitivity was 83.45 % and specificity was 73.56 %.

CONCLUSION

This study indicated that high levels of GPR and TG were risk factors for NAFLD and demonstrated good clinical value in diagnosing NAFLD.

摘要

目的

在临床实践中,用于识别非酒精性脂肪性肝病(NAFLD)的有效生物标志物很少。本研究旨在探讨γ-谷氨酰转肽酶与血小板比值(GPR)联合甘油三酯(TG)在NAFLD中的诊断价值。

方法

共有14415人参加年度体检。进行多因素逻辑回归分析以研究与NAFLD相关的暴露因素。采用Spearman分析评估NAFLD暴露因素之间的相关性。此外,使用受试者工作特征曲线(ROC)分析GPR和TG联合诊断NAFLD的效能。

结果

多因素逻辑回归分析结果显示,体重指数(BMI)(OR = 1.619)、收缩压(SBP)(OR = 1.014)、舒张压(DBP)(OR = 1.028)、GPR(OR = 12.809)和TG(OR = 2.936)均为NAFLD的危险因素,而高密度脂蛋白胆固醇(HDL-C)(OR = 0.215)为保护因素。Spearman相关性分析显示,GPR与SBP、DBP、BMI、TG之间存在显著正相关(p < 0.01),但GPR与HDL-C之间存在负相关(p < 0.01)。TG仅与GPR呈正相关(p < 0.001)。ROC曲线分析表明,GPR联合TG诊断NAFLD的曲线下面积(AUC)为0.855(95%CI:0.819 - 0.891),灵敏度为83.45%,特异度为73.56%。

结论

本研究表明,高水平的GPR和TG是NAFLD的危险因素,在诊断NAFLD方面具有良好的临床价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/9e83d767c144/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/4fb38541842c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/fa5b900604bc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/52851d62290d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/9e83d767c144/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/4fb38541842c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/fa5b900604bc/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/52851d62290d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9da/11367536/9e83d767c144/gr4.jpg

相似文献

1
Clinical value of -glutamyl transpeptidase to platelet ratio and triglyceride measurement in the diagnosis of nonalcoholic fatty liver disease: A cross-sectional study.谷氨酰转肽酶与血小板比值及甘油三酯测定在非酒精性脂肪性肝病诊断中的临床价值:一项横断面研究
Heliyon. 2024 Aug 13;10(16):e36193. doi: 10.1016/j.heliyon.2024.e36193. eCollection 2024 Aug 30.
2
Gamma-Glutamyl Transpeptidase-to-Platelet ratio predicts liver fibrosis in patients with concomitant chronic hepatitis B and nonalcoholic fatty liver disease.γ-谷氨酰转肽酶/血小板比值预测合并慢性乙型肝炎和非酒精性脂肪性肝病患者的肝纤维化。
J Clin Lab Anal. 2022 Aug;36(8):e24596. doi: 10.1002/jcla.24596. Epub 2022 Jul 9.
3
The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.γ-谷氨酰转肽酶与血小板比值用于慢性乙型肝炎和非酒精性脂肪性肝病患者肝纤维化的无创评估
Oncotarget. 2017 Apr 25;8(17):28641-28649. doi: 10.18632/oncotarget.16162.
4
Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease.优化γ-谷氨酰转肽酶/血小板比值和瞬时弹性成像在慢性乙型肝炎合并非酒精性脂肪性肝病患者中识别肝硬化的应用。
Dis Markers. 2019 Dec 5;2019:2585409. doi: 10.1155/2019/2585409. eCollection 2019.
5
Triglyceride glucose-waist circumference: the optimum index to screen nonalcoholic fatty liver disease in non-obese adults.甘油三酯-血糖-腰围:筛查非肥胖成年人非酒精性脂肪肝的最佳指标。
BMC Gastroenterol. 2023 Nov 2;23(1):376. doi: 10.1186/s12876-023-03007-8.
6
Diagnostic value of fibrinogen to prealbumin ratio and gamma-glutamyl transpeptidase to platelet ratio in the progression of AFP-negative hepatocellular carcinoma.纤维蛋白原与前白蛋白比值及γ-谷氨酰转肽酶与血小板比值在甲胎蛋白阴性肝细胞癌进展中的诊断价值
Cancer Cell Int. 2020 Mar 12;20:77. doi: 10.1186/s12935-020-1161-y. eCollection 2020.
7
Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals.非酒精性脂肪性肝病相关危险因素分析:一项基于31718名中国成年个体的回顾性研究。
Front Med (Lausanne). 2023 Jun 29;10:1168499. doi: 10.3389/fmed.2023.1168499. eCollection 2023.
8
FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis.纤维扫描天门冬氨酸转氨酶:诊断高危代谢功能障碍相关脂肪性肝炎的一种更优的非侵入性模型。
World J Gastroenterol. 2024 May 14;30(18):2440-2453. doi: 10.3748/wjg.v30.i18.2440.
9
Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population.传统和非传统脂质指标在日本人群中非酒精性脂肪肝诊断中的应用。
Lipids Health Dis. 2022 Oct 7;21(1):95. doi: 10.1186/s12944-022-01712-z.
10
[Triglyceride-glucose index in non-obese individuals: its association with and predictive value for non-alcoholic fatty liver disease].非肥胖个体的甘油三酯-葡萄糖指数:其与非酒精性脂肪性肝病的关联及预测价值
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Jul 20;44(7):1266-1271. doi: 10.12122/j.issn.1673-4254.2024.07.06.

本文引用的文献

1
mA-Related Angiogenic Genes to Construct Prognostic Signature, Reveal Immune and Oxidative Stress Landscape, and Screen Drugs in Hepatocellular Carcinoma.mA 相关血管生成基因构建预后标志物,揭示肝癌免疫和氧化应激全景,并筛选药物。
Oxid Med Cell Longev. 2022 Sep 30;2022:8301888. doi: 10.1155/2022/8301888. eCollection 2022.
2
The correlation between neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with nonalcoholic fatty liver disease: a cross-sectional study.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值与非酒精性脂肪性肝病的相关性:一项横断面研究。
Eur J Gastroenterol Hepatol. 2022 Nov 1;34(11):1158-1164. doi: 10.1097/MEG.0000000000002439. Epub 2022 Sep 10.
3
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase.
γ-谷氨酰转肽酶与血小板比值可预测丙氨酸氨基转移酶正常的乙肝e抗原阴性慢性乙型肝炎患者的肝损伤
J Clin Transl Hepatol. 2022 Apr 28;10(2):247-253. doi: 10.14218/JCTH.2021.00151. Epub 2021 Jul 14.
4
Gamma-glutamyl transpeptidase-to-platelet ratio as a biomarker of liver disease and hepatic fibrosis severity in paediatric Cystic Fibrosis.γ-谷氨酰转肽酶/血小板比值作为儿童囊性纤维化肝病和肝纤维化严重程度的生物标志物。
J Cyst Fibros. 2022 Mar;21(2):236-242. doi: 10.1016/j.jcf.2021.10.014. Epub 2021 Dec 23.
5
Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study.单核细胞/高密度脂蛋白胆固醇比值与非酒精性脂肪性肝病的相关性:一项横断面研究。
Mediators Inflamm. 2021 Dec 7;2021:6642246. doi: 10.1155/2021/6642246. eCollection 2021.
6
Prognostic value of gamma-glutamyl transpeptidase in liver cirrhosis and hepatocellular cancer regardless of other parameters.无论其他参数如何,γ-谷氨酰转肽酶在肝硬化和肝细胞癌中的预后价值。
Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101708. doi: 10.1016/j.clinre.2021.101708. Epub 2021 Apr 27.
7
Metabolic-associated fatty liver disease and lipoprotein metabolism.代谢相关性脂肪性肝病与脂蛋白代谢。
Mol Metab. 2021 Aug;50:101238. doi: 10.1016/j.molmet.2021.101238. Epub 2021 Apr 20.
8
Till Death Do Us Part-The Multifaceted Role of Platelets in Liver Diseases.至死不渝——血小板在肝脏疾病中的多面角色。
Int J Mol Sci. 2021 Mar 18;22(6):3113. doi: 10.3390/ijms22063113.
9
Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent.非酒精性脂肪性肝病中的甘油三酯:无罪推定。
Trends Pharmacol Sci. 2021 Mar;42(3):183-190. doi: 10.1016/j.tips.2020.12.001. Epub 2021 Jan 16.
10
Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.非酒精性脂肪性肝病瘦型中国成年人的患病率、临床特征、危险因素和指标。
World J Gastroenterol. 2020 Apr 21;26(15):1792-1804. doi: 10.3748/wjg.v26.i15.1792.